News archive

Call picture for JPIAMR Diagnostics and Surveillance call 2023

Research call on AMR Diagnostics and surveillance now open

Jan 16, 2023

The call “Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance” is now open. 

This call aims to fund research projects developing novel or improving existing strategies, tools, technologies and methods for diagnosis and/or One Health AMR surveillance. It involves 22 funding organisations from 18 countries and has a total estimated call budget of 18,8 M€.

Online Consultation: Research and Innovation Objectives for the OH AMR Partnership

Dec 5, 2022

The candidate One Health Antimicrobial Resistance partnership (OH AMR) has been identified by the European Commission as one of the candidate European Partnerships of Horizon Europe. Currently, the Research and Innovation Objectives of OH AMR are under preparation, and we now invite researchers, stakeholders, scientists, policymakers, clinicians, patient groups, AMR-related organisations, and others to provide feedback on the elements included in the Research and Innovations Objectives.

Shadows of people on a colourful background.

Six new networks the area of diagnostics and surveillance

Nov 18, 2022

Six networks have been recommended for funding within the JPIAMR 15th transnational call: Diagnostics and Surveillance Networks. The networks include 228 partners from 40 countries and for the first time, a network focussed on antifungal resistance has been included.

Northern lights

New projects in the area of therapeutics

Nov 18, 2022

Thirteen projects involving 72 partners from 15 different countries have been recommended for funding within the JPIAMR 14th transnational call: Disrupting drug Resistance Using Innovative Design. The call was within the framework of the ERA‐NET JPIAMRACTION and the total funding amount is 15,4 M€.

Call picture for JPIAMR Diagnostics and Surveillance call 2023

Pre-announcement: Research call on AMR diagnostics and surveillance

Nov 18, 2022

We are pleased to pre‐announce the transnational call “Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance”. The call involves 21 funding organisations from 18 countries and has a total estimated call budget of 18,8 M€.

Reports from DESIGN OH AMR consultations available

Oct 5, 2022

In 2022, the Coordination and Support Action (CSA) DESIGN OH AMR has organised a series of stakeholder and expert consultations to collect input to the update of the research and innovation objectives within the JPIAMR SRIA.

Illustration of the Globe with people and animals

Survey on funding instruments by the future OH AMR Partnership programme

Sep 7, 2022

In preparation for the future OH AMR Partnership, JPIAMR invites the research community to share its view on gaps in the AMR funding landscape and the requirements for potential funding mechanisms with impact.

Pills on green background

Main achievements of Therapeutics research projects and networks

May 13, 2022

A report on the outputs, outcome and impact generated by the projects funded in the various JPIAMR transnational research project and network calls under the Therapeutics priority topic has been published.

Social sciences as a cross-cutting theme in JPIAMR research priorities

May 5, 2022

The development of resistance to antibiotics is a biological process, but the context that determines emergence and impact of resistance is underpinned by social aspects. Therefore, it is necessary to identify, understand and evaluate these social aspects to enable the prevention and control of AMR.

Consultation: antiparasitic and antiviral resistance

Apr 29, 2022

The JPIAMR has launched a round of consultation on antiparasitic and antiviral resistance. The information will be used for outlining research and innovation priorities in the Strategic Research and Innovation Agenda (SRIA) on Antimicrobial Resistance and informing the scope and direction of the candidate One Health AMR partnership.